$0.84
$0.00 (0.00%)
End-of-day quote: 05/29/2024
NasdaqGM:AMRN
Amarin Competitors
Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
LLY | Eli Lilly and | NYSE | Outperform | $815.06 | $850.79 | 0.00% | 9 | $733.88B |
JNJ | Johnson & Johnson | NYSE | Outperform | $145.28 | $172.51 | 0.00% | 3 | $349.64B |
AZN | AstraZeneca PLC | LSE | Outperform | £120.28 | £134.03 | 0.00% | 16 | £186.46B |
AMGN | Amgen | NasdaqGS | Outperform | $301.00 | $316.27 | 0.00% | 8 | $161.47B |
PFE | Pfizer | NYSE | Outperform | $28.20 | $31.92 | 0.00% | 6 | $159.80B |
SAN | Sanofi | ENXTPA | Outperform | 88.57€ | 108.19€ | 0.00% | 9 | 110.72€B |
BMY | Bristol-Myers Squibb | NYSE | Hold | $40.25 | $53.19 | 0.00% | 10 | $81.59B |
GILD | Gilead Sciences Inc | NASDAQ | Outperform | $64.08 | $82.77 | 0.00% | 14 | $79.83B |
BAYN | Bayer | XTRA | Hold | 28.06€ | 36.64€ | 0.00% | 4 | 27.56€B |
MTNB | Matinas BioPharma Holdings | NYSEAM | Buy | $0.16 | $0.65 | 0.00% | 0 | $44.04M |
CDXI | Cardax | OTCPK | - | $0.00 | $0.00 | 0.00% | 0 | $0.00M |